All cancer trials are open label, every single one it has nothing to do with who see's the data it is about the poor buggers lining up for something they hope will save their lives. Imagine "Oh sorry mate you got the placebo!" "just lay down over there I will inform your nearest of kin". All participants and doctors involved know what they are giving and what the trial involves, there may be just one patient at a particular center that goes on the trial, all the doctors don't see what's going on at other centers. People say on here all the time it's open label everyone knows what's going on, when in fact it couldn't be further from the truth.
The data is collected collated and reviewed at various intervals, in a dose escalation the trial sponsors or in IMU's Case the Scientific advisory board which has 9 members advises if all clear to proceed with next dose.Not Lesly, she oversee's the whole operation and spends her days answering Steini's and the likes emails, which to her is white noise. Her aim and the companies aim is too cure cancer, if one thinks that is beyond IMU go away, buy some CBA,
Iif IMU do well so will the SP, whingeing and whining here all day is counter productive and tough on your mental health..
IMU Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)